geranylgeraniol has been researched along with Precancerous Conditions in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Conti, A; de Moura EspĂndola, R; Heidor, R; Mazzantini, RP; Moreno, FS; Ong, TP | 1 |
1 other study(ies) available for geranylgeraniol and Precancerous Conditions
Article | Year |
---|---|
Geranylgeraniol and beta-ionone inhibit hepatic preneoplastic lesions, cell proliferation, total plasma cholesterol and DNA damage during the initial phases of hepatocarcinogenesis, but only the former inhibits NF-kappaB activation.
Topics: Animals; Anticarcinogenic Agents; Apoptosis; Cell Proliferation; Cholesterol; Corn Oil; Diterpenes; DNA Damage; Enzyme Activation; Hepatocytes; Liver Neoplasms, Experimental; Male; NF-kappa B; Norisoprenoids; Precancerous Conditions; Rats; Rats, Wistar; Transcription Factor RelA | 2005 |